Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-11-22
2009-02-10
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C435S326000, C435S346000, C530S388100, C530S388200
Reexamination Certificate
active
07488807
ABSTRACT:
Monoclonal antibodies, and antigen binding fragments thereof, which bind to Protein A ofStaphylococcus aureusare provided.
REFERENCES:
patent: 4741900 (1988-05-01), Alvarez et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5594116 (1997-01-01), Niles et al.
patent: 6177084 (2001-01-01), Foster et al.
patent: 6340571 (2002-01-01), Merlin et al.
patent: 6841154 (2005-01-01), Foster et al.
patent: 6994855 (2006-02-01), Foster et al.
patent: 7122641 (2006-10-01), Vedantham et al.
patent: 2006/0051820 (2006-03-01), Horii et al.
patent: 63-273495 (1988-11-01), None
patent: WO 86/02358 (1986-04-01), None
patent: WO 90/02809 (1990-03-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/09690 (1992-06-01), None
patent: WO 92/15679 (1992-09-01), None
patent: WO 92/18619 (1992-10-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO 93/01288 (1993-01-01), None
Ackermann et al. Biotechnology and Bioengineering 1995, 45:97-106.
Harris et al. Biotechnology 1993 11:1293-1297.
American Type Culture Collection, “ATTC No. 12228,” organism:Staphylococcus epidermis; designation: FDA strain PCI 1200 [online]; Manassas, VA [retrieved on Mar. 5, 2007] Retrieved from the Internet:; 3 pgs.
American Type Culture Collection, “ATTC No. 25923,” organism:Staphylococcus aureussubsp.aureusRosenbach; designation: Seattle 1945 [online]; Manassas, VA [retrieved on Mar. 5, 2007] Retrieved from the Internet:; 4 pgs.
Ausubel et al. (eds),Current Protocols in Molecular Biology, vol. 1; John Wiley & Sons, Inc., New York, NY; 1994; title page, publisher's page, and table of contents only; 12 pgs.
Chothia et al., “Canonical structures for the hypervariable regions of immunoglobulins,”J. Mol. Biol., Aug. 20, 1987; 196(4): 901-917.
Davis et al.,Basic Methods in Molecular Biology; McGraw-Hill Profession: New York, NY; 1986, title page, publisher's page, and table of contents only.
Decker,Immunology Tutorials, Antibody. [Retrieved Nov. 13, 2006]. University of Arizona. Jan. 27, 2006. Retrieved from the Internet:; 11 pgs.
Frank et al., “High-yield expression, refolding, and purification of penicillin-binding protein 2a from methicillin-resistantStaphylococcus aureusstrain 27R.”Protein Expression and Purification, 1995; 6:671-675.
Goding,Monoclonal Antibodies: Principles and Practice; Production and Application of Monoclonal Antibodies in Cell Biology, Biochemistry, and Immunology; Academic Press: New York, NY; 1986; pp. 59-103.
Harlow et al.,Antibodies: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY; 1988; title page, publisher's page, and table of contents only, 9 pgs.
Hodgkinson et al., “Selective elution of immunoadsorbed anti-(human prolactin) immunoglobulins with enhanced immunochemical properties,”Biochem. J., 1982; 205:535-541.
Holliger et al., “‘Diabodies’: small bivalent and bispecific antibody fragments,”Proc. Nat'l Acad. Sci. USA, Jul. 15, 1993; 90(14):6444-6448.
Introduction to Antibodies, Introduction [online]. Millipore Corporation; Temecula, CA. [Retrieved on Mar. 5, 2007]. Retrieved from the Chemicon website using Internet:;8 pgs.
Jones et al., “Replacing the complementarity-determining regions in a human antibody with those from a mouse,”Nature, May 29-Jun. 4, 1986; 32(6069):522-525.
Kabat et al.,Sequences of Proteins of Immunological Interest, Fifth Edition; U.S. Department of Health and Human Services: Bethesda, MD; 1991, NIH Publication No. 91-3242; title page, publisher's page, and table of contents only.
Kimball,Biology, 6threvised edition; Antibody Affinity [online]. Sep. 9, 2003 [Retrieved Mar. 5, 2007]. Retrieved from the Biology Pages website Internet:; 6 pgs.
Kohler and Milstein, “Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion,”Eur. J. Immunol., Jul. 1976; 6(7): 511-519.
Kostelny et al., “Formation of a bispecific antibody by the use of leucine zippers,”J. Immunol., Mar. 1, 1992; 148(5):1547-1553.
Lu et al., “Penecillin-binding protein 2a from methicillin-resistantStaphylococcus aureus: Kinetic characterization of its interactions with beta-lactams using electrospray mass spectrometry,”Biochemistry, May 18, 1999; 38(20): 6537-6546.
Orlandi et al., “Cloning immunoglobulin variable domains for expression by the polymerase chain reaction,”Proc. Nat'l Acad. Sci. USA, May 1989; 86(10):3833-3837.
Sambrook et al.,Molecular Cloning: A Laboratory Manual, Books 1-3; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY; 1989; title page, publisher's page, and table of contents only, 30 pgs.
Singer II et al., “Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences,”J. Immunol., Apr. 1, 1993; 150(7):2844-2857.
Smith and Petrenko, “Phage Display,”Chem. Rev., Apr. 1, 1997; 97(2):391-410.
Smith and Waterman, “Comparison of Biosequences,”Advances in Applied Mathematics, 1981; 2:482-489.
Songsivilai and Lachmann, “Bispecific antibody: a tool for diagnosis and treatment of disease,”Clin. Exp. Immunol., Mar. 1990; 79(3):315-321.
Takeda et al., “Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences,”Nature, Apr. 4-10, 1985; 314(6010):452-454.
Traunecker et al., “Bispecific single chain molecules (janusins) target cytotoxic lymphocytes on HIV infected cells,”EMBO J., Dec. 1991; 10(12):3655-3659.
Traunecker et al., “Janusin: new molecular design for bispecific reagents,”Int. J. Cancer Suppl., 1992; 7:51-52.
U.S. Appl. No. 60/867,102, filed on even date herewith, and entitled “Method of Preparing a Mucosal Sample,” filed Nov. 22, 2006.
U.S. Appl. No. 11/562,759, filed on even date herewith, and entitled “Antibody With Protein A Selectivity,” present application filed Nov. 22, 2006.
U.S. Appl. No. 11/562,747, filed on even date herewith, and entitled “Antibody With Protein A Selectivity,” filed Nov. 22, 2006.
U.S. Appl. No. 60/867,089, filed on even date herewith, and entitled “Specific Antibody Selection by Selective Elution Conditions,” filed Nov. 22, 2006.
U.S. Appl. No. 60/867,020, filed on even date herewith, and entitled “Inactivated and Dried Biological Preparations,” filed Nov. 22, 2006.
U.S. Appl. No. 60/867,093, filed on even date herewith, and entitled “Method of Analyzing a Sample for a Microorganism,” filed Nov. 22, 2006.
U.S. Appl. No. 60/867,016, filed on even date herewith, and entitled “Method of Capturing Bacterial Whole Cells,” filed Nov. 22, 2006.
U.S. Appl. No. 60/867,012, filed on even date herewith, and entitled “Systems and Methods for Sample Preparation Using Caps and Vials,” filed Nov. 22, 2006.
U.S. Appl. No. 60/867,098, filed on even date herewith, and entitled “Method of Analyzing a Sample for a Microorganism,” filed Nov. 22, 2006.
U.S. Appl. No. 60/867,073, filed on even date herewith, and entitled “Systems and Methods for Sample Preparation Using a Fluidic Device,” filed Nov. 22, 2006.
Mach Patrick A.
Reif-Wenner Mara S.
3M Innovative Properties Company
Gambel Phillip
Wen Sharon
Williams Michael G.
LandOfFree
Antibody with protein A selectivity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody with protein A selectivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody with protein A selectivity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4100804